2026 BD opportunity scan for Jiangsu Zhongxin Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outre

2026 BD opportunity scan for Jiangsu Yangtze River Pharmaceutical Group Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signal

2026 BD opportunity scan for Jiangsu Vcare PharmaTech Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rat

2026 BD opportunity scan for Jiangsu Simcere Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outrea

2026 BD opportunity scan for Jiangsu Huayi Technology Co. Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rati

2026 BD opportunity scan for Jiangsu Hengrui Pharmaceuticals Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outre

2026 BD opportunity scan for Jiangsu Hansoh Pharmaceutical Group Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and o

2026 BD opportunity scan for Jiangsu Aosaikang Pharmaceutical Co. Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outre

2026 BD opportunity scan for Jiangsu Alphamab Biopharmaceuticals Co., Ltd: pipeline stage, evidence package, IP risk, deal precedent, financial signals and ou

2026 BD opportunity scan for Jiangsu Aidea Pharmaceutical Group Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and ou

2026 BD opportunity scan for Jewim Pharmaceutical (Shandong) Co., Ltd: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outrea

2026 BD opportunity scan for Jean Perrin Center: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.